RICHMOND, Va.--(BUSINESS WIRE)--Feb. 8, 2006--Commonwealth Biotechnologies, Inc. (NASDAQ: CBTE), a solutions provider to the global biotechnology industry, government agencies, pharmaceutical companies, and academic institutions, today released its financial results for the 2005 fiscal year and the fourth quarter ended December 31, 2005. The Company’s 10-KSB is expected to be released on or about March 31, 2006.
